🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. Zipalertinib Placebo Tablets is a film-coated tablet that does not contain the active ingredient, zipalertinib., Cisplatin Hikma 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Zipalertinib, Pemetrexed Fresenius Kabi 25 mg/ml concentrate for solution for infusion, Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Taiho Pharma Netherlands B.V.

    Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations

    phase 3 small molecule active

    1 trial

  2. Zodasiran

    Arrowhead Pharmaceuticals Ireland Limited

    Homozygous Familial Hypercholesterolemia

    phase 3 small molecule active

    1 trial

  3. Zoladex 3,6 mg implante en jeringa precargada, Decapeptyl semestral 22,5 mg polvo y disolvente para suspensión de liberación prolongada inyectable., Eligard semestral 45 mg polvo y disolvente para solución inyectable., Bicalutamida Aristo 50 mg comprimidos recubiertos con película EFG

    The George Institute

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  4. Zoledronic acid

    United Therapeutics Europe Ltd

    Osteoporosis

    phase 3 small molecule terminated

    1 trial

  5. Zometa 4 mg/100 ml solution for infusion, XGEVA 120 mg solution for injection in pre-filled syringe

    CERO THERAPEUTICS HOLDINGS, INC.

    Patients, men or women over 18 old, with inoperable vertebral bone metastases who must beneficit treatment with stereotactic radiotherapy

    phase 3 small molecule active

    1 trial

  6. Zovirax 50 mg/g crema, Lipovir 50 mg/g Gel, Placebo

    Lacuna Pharma Pty Ltd

    Recurrent herpes labialis (RHL)

    phase 3 small molecule active

    1 trial

  7. Zydelig 100 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Zydelig 150 mg film-coated tablets, Truxima 500 mg concentrate for solution for infusion, Truxima 500 mg concentrate for solution for infusion, Truxima 500 mg concentrate for solution for infusion, Zydelig 100 mg film-coated tablets, Bendamustin Hikma 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Bendamustin Hikma 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer I

    Lacuna Pharma Pty Ltd

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  8. abamectin and fenpyroximate

    United Therapeutics Europe Ltd

    Malaria

    phase 3 small molecule terminated

    1 trial

  9. aceneuramic acid extended-release (Ace-ER)

    Ultragenyx UK Limited

    Hereditary Inclusion Body Myopathy

    phase 3 small molecule completed

    1 trial

  10. acyclovir

    Ultragenyx UK Limited

    Herpes Simplex

    phase 3 small molecule completed

    2 trials

  11. administering RASI (the trade name or universal name will not be stipulated) before stenting

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carotid Stenosis

    phase 3 small molecule active

    1 trial

  12. adoptive immunotherapy

    Chinese PLA General Hospital

    Hepatocellular Carcinoma

    phase 3 mab completed

    1 trial

  13. amifampridine phosphate

    CATALYST PHARMACEUTICALS, INC.

    Myasthenic Syndromes, Congenital

    phase 3 small molecule completed

    1 trial

  14. ampreloxetine

    Theravance Biopharma Ireland Umited

    Symptomatic Neurogenic Orthostatic Hypotension

    phase 3 small molecule active

    4 trials

  15. asparaginase

    United Therapeutics Europe Ltd

    Lymphoma

    phase 3 small molecule active

    1 trial

  16. avapritinib

    Blueprint Medicines (Netherlands) B.V.

    GIST

    phase 3 small molecule completed

    1 trial

  17. avoralstat

    Biocryst

    Hereditary Angioedema

    phase 3 small molecule terminated

    1 trial

  18. bLF (Bovine lactoferrin)

    United Therapeutics Europe Ltd

    Neonatal Sepsis

    phase 3 other active

    1 trial

  19. balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg

    AstraZeneca

    Heart Failure and Impaired Kidney Function

    phase 3 small molecule active

    1 trial

  20. bamlanivimab 7000mg

    SAB Biotherapeutics

    Coronavirus

    phase 3 mab completed

    1 trial

  21. bapineuzumab

    Pfizer

    Alzheimer Disease

    phase 3 small molecule terminated

    1 trial

  22. belapectin

    GALECTIN THERAPEUTICS INC

    Prevention of Esophageal Varices

    phase 3 small molecule terminated

    1 trial

  23. bempedoic acid

    Esperion Therapeutics

    Hypercholesterolemia

    phase 3 small molecule completed

    5 trials

  24. bempegaldesleukin

    Nektar Therapeutics UK Limited

    Renal Cell Carcinoma

    phase 3 mab terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources